Product logins

Find logins to all Clarivate products below.


Heart Valve Devices – Market Insights – Japan

The Japanese heart valve device market will experience modest growth, primarily driven by the increasing adoption of THV devices. Positive clinical outcomes and the introduction of innovative products will expand the eligible patient pool, fueling sustained growth in the heart valve device market.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for heart valve devices in Japan from 2019 through 2033.

Transcatheter replacement therapies will be the driving the Japanese heart valve replacement device market.

Which new TAVI devices are poised to enter the market? What impact will these newer devices have on market dynamics and market growth?

What new transcatheter replacement devices have been approved in the Japanese market? How will they impact the overall heart valve device market?

When is TMVI therapy expected to enter the Japanese market? What TMVI devices are in development?

How will MHLW reimbursement affect TAVI adoption?

How the growth in the THV device market is going to impact the surgical market?

The competitive landscape for the THV device market is evolving.

Which competitors have the most diverse portfolios in the heart valve device space?

How companies are gaining a competitive edge through mergers and acquisitions?

MHLW reimbursement revisions will affect the Japanese heart valve device market.

How has Japan’s regulatory framework changed to align with global regulatory requirements?

What is the impact of Japan’s regulatory approval process on product launches in Japan?

What other factors will affect ASP trends?

Clinical trial results play an important factor in the heart valve device market.

How are clinical studies and guidelines impacting the uptake of THV devices?

What segments have been the most impacted by clinical results?

What will be the market impact of the approval of expanded indications for TAVI?

What technologies are larger players focusing on, and how will the first-mover advantage benefit these competitors?

Table of contents


Related Medtech Insights Reports

Report
Dialysis Access Treatment Devices – Market Insights – United States
The US dialysis access treatment device market will grow at a moderate rate due to the increasing adoption of innovative products, positive clinical data, and rising ASPs of specific devices like…
Report
Cardiac Rhythm Management Devices – Market Insights – Japan
The Japanese CRM device market will grow over the forecast period. The introduction of novel products—such as the Aurora EV-ICD and dual-chamber leadless pacemakers—and favorable reimbursement…
Report
Neurovascular Devices – Market Insights – Asia Pacific
The Asia Pacific neurovascular device market will grow strongly through the forecast period, driven by various factors such as rising procedure volumes, product launches, and increasing…
Report
Neurovascular Devices – Market Insights – Europe
The European neurovascular device market is poised to experience strong growth through 2034. This growth will be driven by the introduction of newly developed technologies, increasing adoption of…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for growth, driven by increasing PCI volumes for complex CAD cases and the adoption of innovative devices and…